HEART FAILURE-ICD & CRT

SUMMARY

1. The 2013 ACC/ AHA guideline recommends lCD for primary prevention of sudden cardiac death & mortality reduction in patients who are 40 days post-MI, EF < 35% & NYHA II/III symptoms on optimal medical therapy.

2. Cardiac resynchronization therapy (CRT) involves pacing the right and left ventricles and is recommended for patients with EF < 35%, sinus rhythm, LBBB with QRS duration of > 150 ms & with NYHA II/III symptoms.

Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].